Do New Hospital Price Transparency Regulations Reflect Value in Arthroplasty?

Taylor D'Amore, MD; Graham S. Goh, MD; P. Maxwell Courtney, MD; Gregg R. Klein, MD


J Am Acad Orthop Surg. 2022;30(8):e658-e663. 

In This Article


Few hospitals are fully compliant with the new CMS price transparency regulations. This study found a wide range of hospital charges, cash prices, and payer rates for THA and TKA without any correlation with postoperative complications or readmissions. Although efforts by CMS to increase price transparency should be welcomed, increased costs should be justified by higher quality arthroplasty care in the era of value-based care.